Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study

Search results

• Study finds missed opportunities with COVID antivirals on Australian PBS

  Lopez, D., Pritchard, D., Sanfilippo, F., Kelty, E., Page, A., Etherton-Beer, C., De Almeida, O. & Preen, D.

  11/07/24

  1 item of Media coverage

  Press/Media: Press / Media